Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The phrase "multiple physiological targets" designates several biological molecules or pathways—including proteins, enzymes, receptors, ion channels, and transcription factors—that can be modulated by endogenous substances or therapeutic agents to alter physiological or pathological states[1][7][5]. It is commonly used when referring to strategies that impact a network of molecular entities (such as in multi-target drug or polypharmacology approaches) for complex diseases like cancer, neurodegenerative disorders, or cardiovascular disease[5][7]. Because it does not specify a unique molecular identity, abbreviation, or standard aliases, it cannot be treated as a canonical therapeutic target. The term is overly broad and should be replaced with the specific names of individual molecular targets for structured data.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Multiple physiological targets.